test

Jens Kildal

@Dnb Asset Management As

Latest period2024 - Q3ReportedManaged Assets$22.15BTotal holdings715
Assets growth rate5.68%Assets growth rate (2-Q avg)7.49%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Dnb Asset Management As's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 715 positions.

Assets under management

The assets under management (AUM) of Dnb Asset Management As over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 22.15B in assets, with a quarterly growth rate of 5.68% and a 2-quarter average growth rate of 7.49%. The portfolio is managed by Jens Kildal, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BPMCBlueprint Medicines Corp
Recent Activity
New Position
0.01%
$805,953
8,713 shares@ $92.51 avg price
GLBEGlobal E Online Ord
Recent Activity
New Position
0.01%
$682,810
17,763 shares@ $38.45 avg price
PCVXVaxcyte Inc
Recent Activity
New Position
0.01%
$664,079
5,812 shares@ $114.26 avg price
SMMTSummit Therapeutics Inc
Recent Activity
New Position
0.01%
$630,063
28,770 shares@ $21.9 avg price
CRSPCrispr Therapeutics Ag
Recent Activity
New Position
0.01%
$555,069
11,815 shares@ $46.99 avg price
BEAMBeam Therapeutics Inc
Recent Activity
New Position
0.01%
$509,576
20,799 shares@ $24.51 avg price
XPXp Inc
Recent Activity
New Position
0.01%
$505,298
28,166 shares@ $17.94 avg price
ALKSAlkermes Plc
Recent Activity
New Position
0.01%
$415,064
14,829 shares@ $28.0 avg price
LILMFLilium N V
Recent Activity
New Position
0.01%
$379,549
490,183 shares@ $0.78 avg price
GERNGeron Corp
Recent Activity
New Position
0.01%
$356,280
78,649 shares@ $4.54 avg price